Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
The company is a manufacturer and distributer of pharmaceutical and neutraceutical products.
Alkem Laboratories Limited, is a listed public company incorporated on 08 August, 1973. It is classified as a public limited company and is located in , Maharashtra. It's authorized share capital is INR 50.00 cr and the total paid-up capital is INR 23.91 cr.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Sujjain Suresh Talwar | 01756539 | 3 years |
| Whole-time Director | Srinivas Balmiki Prasad Singh
Shareholder
|
06744441 | 3 years |
| Managing Director | Sandeep Singh
Shareholder
|
01277984 | 12 years |
| Whole-time Director | Basudeo Narayan Singh
Shareholder
|
00760310 | 52 years |
| Whole-time Director | Mritunjay Kumar Singh
Shareholder
|
00881412 | 18 years |
| Director | Laxmana Ranjal Shenoy | 00074761 | 1 years |
| Whole-time Director | Sarvesh Singh
Shareholder
|
01278229 | 6 years |
| Director | Narendra Aneja | 00124302 | 6 years |
| Whole-time Director | Madhurima Singh
Shareholder
|
09137323 | 4 years |
| Director | Neela Bhattacherjee | 01912483 | 1 years |
| Director | Diwakar Gupta | 01274552 | 1 years |
| Director | Rajeev Kher | 01192524 | 1 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CitiBank N.A.
No. of Loans: 1
Total Amount : 342.0 cr
HDFC Bank Limited
No. of Loans: 1
Total Amount : 270.3 cr
Kotak Mahindra Bank Limited
No. of Loans: 2
Total Amount : 180.0 cr
ICICI Bank Limited
No. of Loans: 1
Total Amount : 108.0 cr
State Bank of India
No. of Loans: 2
Total Amount : 100.2 cr
Bank of India
No. of Loans: 1
Total Amount : 85.0 cr
MEMBER SECRETARY SINGLE WINDOW CLEARANCE AGENCY
No. of Loans: 1
Total Amount : 0.3 cr
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Ascend Laboratories SDN BHD | Malaysia | - | - |
| S & B Holdings B.V | Netherlands | - | - |
| Pharmacor Limited | New Zealand | - | - |
| Alkem Laboratories Corporation | Philippines | - | - |
| Enzene Inc | United States | - | - |
| Ascend Laboratories (Pty) Limited (formerly known as Alkem Laboratories (Pty) Limited) | South Africa | - | - |
| ThePharmaNetwork, LLC | United States | - | - |
| Ascend Laboratories LLC | United States | - | - |
| Ascend Laboratories (UK) Limited | United Kingdom | - | - |
| ALKEM FOUNDATION | Maharashtra | 2010 | ₹ 1.0 L |
| Pharmacor Pty Limited | Australia | - | - |
| Ascend Laboratories Limited | Canada | - | - |
| Pharma Network SpA | Chile | - | - |
| Ascend Laboratories SAS | Colombia | - | - |
| CONNECT 2 CLINIC PRIVATE LIMITED | Maharashtra | 2020 | ₹ 1.5 Cr |
| S&B Pharma LLC | United States | - | - |
| CACHET PHARMACEUTICALS PRIVATE LIMITED | Bihar | 1978 | ₹ 17.8 L |
| Ascend Laboratories SpA | Chile | - | - |
| ENZENE BIOSCIENCES LIMITED | Maharashtra | 2006 | ₹ 51.4 Cr |
| Ascend GmbH (Formerly known as Alkem Pharma GmbH) | Germany | - | - |
| INDCHEMIE HEALTH SPECIALITIES PRIVATE LIMITED | Maharashtra | 1986 | ₹ 25.0 L |
| The PharmaNetwork, LLP | Kazakhstan | - | - |
| Alkem Laboratories Korea Inc | Korea, Republic Of | - | - |
| Ascend Laboratories S.A. DE C.V | Mexico | - | - |
| ALKEM MEDTECH PRIVATE LIMITED | Indonesia | - | - |
| S&B Holdings S.a.r.l. (Previously known as S&B Holdings B.V with principle place of business based a | Netherlands | - | - |
| Ascend Laboratories (Pty) Limited | South Africa | - | - |
| Ascend GmbH | Germany | - | - |
| Ascend Laboratories S.A. DE C.V. | Mexico | - | - |
| ALKEM MEDTECH PRIVATE LIMITED | 2024 | ₹ 380.4 Cr |
Read more
The incorporation date of ALKEM LABORATORIES LIMITED is 08 August, 1973
The authorized share capital of ALKEM LABORATORIES LIMITED is INR ₹ 50.0 Cr.
The paid-up capital of ALKEM LABORATORIES LIMITED is INR ₹ 23.9 Cr.
The registered address of ALKEM LABORATORIES LIMITED is ALKEM HOUSE, SENAPATI BAPAT MARG LOWER PAREL, MUMBAI, Maharashtra, India, 400013 - 400013
The CIN number of ALKEM LABORATORIES LIMITED is L00305MH1973PLC174201.